Skip to main content
All lobbying filings

HORIZON GOVERNMENT AFFAIRS

Lobbying for CENCORA FKA AMERISOURCEBERGEN CORPORATION · Pharmaceutical Services

 Filing 1st Quarter - Report
1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $50,000.00 income · posted Apr 7, 2025

Official filing document

 Bills named in this filing 3
  • S 2764
    Protecting Patient Access to Cancer and Complex Therapies Act of 2023
  • HR 5391
    Protecting Patient Access to Cancer and Complex Therapies Act
  • HR 5526
    Seniors’ Access to Critical Medications Act of 2024
 Lobbying activity 1
Health Issues

Medicare Part B Issues; Drug pricing and access, including Inflation Reduction Act; Drug shortage issues; Medicare physician reimbursement issues; HR 405-EMSSA; HR 5378-Lower Costs, More Transparency Act; S.2973-Modernizing and Ensuring PBM Accountability Act; HR 5526-Seniors'Access to Critical Medications Act of 2023; S.2764 and HR 5391, the Protecting Patient Access to Cancer and Complex Therapies Act, Seniors Access to Critical Medications Act (H.R. 5526).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem